Related Experiment Video
Updated: Sep 21, 2025
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.8K
Interdisciplinary analysis of drugs: Structural features and clinical data
Daniel Austin1, Kumari Biswas1, Kailee Pollock1
1School of Pharmacy, Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
Journal of Clinical and Translational Science
|June 2, 2022
Summary
This study links drug chemical structures to adverse drug reactions (ADRs). Specific functional groups like piperazine are linked to higher central nervous system (CNS) ADRs, while others like amides are linked to lower gastrointestinal (GI) or CNS ADRs.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Clinical Data Analysis
Background:
- Chemical structure is crucial in early drug development.
- Its role in safety and efficacy analysis diminishes post-approval.
- This study explores using clinical data and drug structures for decision-making.
Purpose of the Study:
- To identify associations between drug structural features and adverse drug reactions (ADRs).
- To explore the utility of this strategy for clinical decision-making and drug development.
Main Methods:
- Classified chemical functional and structural groups (SGs) for 261 drugs.
- Obtained gastrointestinal (GI) and central nervous system (CNS) ADR incidence from a clinical database.
- Analyzed correlations between SGs and ADR incidence (≥10%).
Main Results:
- Identified eight statistically significant associations.
- Piperazine and methylene groups correlated with higher CNS ADR rates.
- Amides, secondary alcohols, and di-substituted phenyl groups correlated with lower GI or CNS ADR rates.
Conclusions:
- Establishes a methodology linking drug chemical properties to ADR risks.
- This approach can aid clinical decision-making for equivalent therapies.
- Further research is needed to fully understand and build upon these associations.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:26Drug Administration and Therapy Phases: Overview
792
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
792
01:21Pharmacodynamics: Overview and Principles
2.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.2K
01:24Principles of Drug Action
6.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.7K
01:26Drug Discovery: Overview
8.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.9K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K